140 related articles for article (PubMed ID: 15507763)
1. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.
Nunoi H; Ishibashi F; Mizukami T; Hidaka F
Jpn J Infect Dis; 2004 Oct; 57(5):S25-6. PubMed ID: 15507763
[TBL] [Abstract][Full Text] [Related]
2. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene.
von Goessel H; Hossle JP; Seger R; Gungor T
Exp Hematol; 2006 Apr; 34(4):528-35. PubMed ID: 16569599
[TBL] [Abstract][Full Text] [Related]
5. A splice-supporting intronic mutation in the last bp position of a cryptic exon within intron 6 of the CYBB gene induces its incorporation into the mRNA causing chronic granulomatous disease (CGD).
Rump A; Rösen-Wolff A; Gahr M; Seidenberg J; Roos C; Walter L; Günther V; Roesler J
Gene; 2006 Apr; 371(2):174-81. PubMed ID: 16516412
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
Condino-Neto A; Newburger PE
Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042
[TBL] [Abstract][Full Text] [Related]
7. A donor splice site mutation in intron 1 of CYBA, leading to chronic granulomatous disease.
de Boer M; Hartl D; Wintergerst U; Belohradsky BH; Roos D
Blood Cells Mol Dis; 2005; 35(3):365-9. PubMed ID: 16157492
[TBL] [Abstract][Full Text] [Related]
8. The search for a genetic defect in Polish patients with chronic granulomatous disease.
Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
[TBL] [Abstract][Full Text] [Related]
9. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22(0)) leading to the activation of a cryptic splice site in intron 4.
Stasia MJ; Bordigoni P; Martel C; Morel F
Hum Genet; 2002 May; 110(5):444-50. PubMed ID: 12073015
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox.
Patiño PJ; Perez JE; Lopez JA; Condino-Neto A; Grumach AS; Botero JH; Curnutte JT; García de Olarte D
Hum Mutat; 1999; 13(1):29-37. PubMed ID: 9888386
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).
Gérard B; El Benna J; Alcain F; Gougerot-Pocidalo MA; Grandchamp B; Chollet-Martin S
Hum Mutat; 2001 Aug; 18(2):163. PubMed ID: 11462241
[TBL] [Abstract][Full Text] [Related]
12. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
[TBL] [Abstract][Full Text] [Related]
13. Genetic and biochemical background of chronic granulomatous disease.
Jurkowska M; Bernatowska E; Bal J
Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report.
Wolach B; Ash S; Gavrieli R; Stark B; Yaniv I; Roos D
Am J Hematol; 2005 Sep; 80(1):50-4. PubMed ID: 16138344
[TBL] [Abstract][Full Text] [Related]
15. Gene symbol: CYBB. Disease: X-linked chronic granulomatous disease.
Stasia MJ
Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818813
[No Abstract] [Full Text] [Related]
16. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB.
Stasia MJ; Brion JP; Boutonnat J; Morel F
J Infect Dis; 2003 Nov; 188(10):1593-604. PubMed ID: 14624387
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of chronic granulomatous disease in a series of 80 kindreds: identification of 31 novel mutations.
Kannengiesser C; Gérard B; El Benna J; Henri D; Kroviarski Y; Chollet-Martin S; Gougerot-Pocidalo MA; Elbim C; Grandchamp B
Hum Mutat; 2008 Sep; 29(9):E132-49. PubMed ID: 18546332
[TBL] [Abstract][Full Text] [Related]
18. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of chronic granulomatous disease in a male fetus.
Yavuz Köker M; Metin A; Ozgür TT; de Boer M; Roos D
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):57-61. PubMed ID: 19279361
[TBL] [Abstract][Full Text] [Related]
20. Genetical analysis of all Danish patients diagnosed with chronic granulomatous disease.
Jakobsen MA; Katzenstein TL; Valerius NH; Roos D; Fisker N; Mogensen TH; Jensen PØ; Barington T
Scand J Immunol; 2012 Nov; 76(5):505-11. PubMed ID: 22924696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
